Polycystic Ovarian Syndrome Clinical Trials

8 recruiting

Polycystic Ovarian Syndrome Trials at a Glance

11 actively recruiting trials for polycystic ovarian syndrome are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Cairo, and Erlangen. Lead sponsors running polycystic ovarian syndrome studies include Centre Hospitalier Universitaire Vaudois, Chinese Medicine Clinical Research Centre, Liverpool Hospital, and Cairo University.

Browse polycystic ovarian syndrome trials by phase

Treatments under study

About Polycystic Ovarian Syndrome Clinical Trials

Looking for clinical trials for Polycystic Ovarian Syndrome? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polycystic Ovarian Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polycystic Ovarian Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Vitamin D DeficiencyPolycystic Ovarian Syndrome in Adolescent Females
Yale University60 enrolled1 locationNCT04355572
Recruiting
Phase 1

Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome

InfertilityPolycystic Ovarian Syndrome (PCOS)Herbal Medicine+1 more
Jinnah Postgraduate Medical Centre116 enrolled1 locationNCT07399535
Recruiting

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Obesity (Disorder)Polycystic Ovarian Syndrome in Adolescent Females
Nemours Children's Clinic20 enrolled1 locationNCT07169136
Recruiting

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Polycystic Ovarian SyndromeAnti-Müllerian HormonePremature Ovarian Insufficiency+1 more
Chinese University of Hong Kong300 enrolled1 locationNCT05858307
Recruiting
Not Applicable

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

Polycystic Ovarian Syndrome (PCOS)
Cairo University122 enrolled1 locationNCT06793904
Recruiting
Phase 1

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

Polycystic Ovarian Syndrome
HITEC-Institute of Medical Sciences42 enrolled1 locationNCT06813118
Recruiting

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Polycystic Ovarian Syndrome (PCOS)
University Hospital Erlangen380 enrolled1 locationNCT06642831
Recruiting
Not Applicable

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

Polycystic Ovarian Syndrome
Peking University Third Hospital300 enrolled1 locationNCT06587698
Recruiting

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Kallmann SyndromeHypogonadotropic HypogonadismHypothalamic Amenorrhea+5 more
Centre Hospitalier Universitaire Vaudois2,000 enrolled1 locationNCT01601171
Recruiting
Phase 3

Diosmin plus cabergoline for prevention of Ovarian Hyperstimulation Syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI)

Ovarian Hyperstimulation SyndromePCO (polycystic ovarian syndrome)infertile women
khalid abd aziz mohamed250 enrolled1 locationACTRN12614000535673
Recruiting

Acupuncture treatment for menstrual disorder in women with Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome
Chinese Medicine Clinical Research Centre, Liverpool Hospital99 enrolled1 locationACTRN12609000073202